Pluri Inc. Files 10-Q for Q4 2024

TL;DR

Pluri Inc. 10-Q filed for Dec 31, 2024. Check financials.

AI Summary

Pluri Inc. filed its 10-Q report for the quarterly period ended December 31, 2024. The company, formerly known as Pluristem Therapeutics Inc., is incorporated in Nevada and operates in the biological products sector. Its business address is located in Haifa, Israel.

Why It Matters

This filing provides investors with an update on Pluri Inc.'s financial performance and operational status for the fourth quarter of 2024.

Risk Assessment

Risk Level: medium — As a 10-Q filing, it contains detailed financial information and operational updates which can significantly impact stock price, but it does not represent a new event or crisis.

Key Players & Entities

• Pluri Inc. (company) — Registrant
• December 31, 2024 (date) — Quarterly period end date
• Pluristem Therapeutics Inc. (company) — Former company name
• Nevada (jurisdiction) — State of incorporation
• Haifa (location) — Business address city

FAQ

Key Financial Figures

• $0.00001 — ch registered Common Shares, par value $0.00001 PLUR The Nasdaq Capital Market Securi
• $1 — ty $ 30,861 $ 39,527 (*) Less than $1 The accompanying notes are an integra

Filing Documents

• ea0229816-10q_pluri.htm (10-Q) — 555KB
• ea022981601ex10-4_pluri.htm (EX-10.4) — 6KB
• ea022981601ex31-1_pluri.htm (EX-31.1) — 9KB
• ea022981601ex31-2_pluri.htm (EX-31.2) — 9KB
• ea022981601ex32-1_pluri.htm (EX-32.1) — 3KB
• ea022981601ex32-2_pluri.htm (EX-32.2) — 3KB
• ex10-4_001.jpg (GRAPHIC) — 12KB
• 0001213900-25-012189.txt ( ) — 3381KB
• plur-20241231.xsd (EX-101.SCH) — 26KB
• plur-20241231_cal.xml (EX-101.CAL) — 31KB
• plur-20241231_def.xml (EX-101.DEF) — 138KB
• plur-20241231_lab.xml (EX-101.LAB) — 292KB
• plur-20241231_pre.xml (EX-101.PRE) — 151KB
• ea0229816-10q_pluri_htm.xml (XML) — 313KB

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from __________ to __________ Commission file number 001-31392 PLURI INC. (Exact name of registrant as specified in its charter) Nevada 98-0351734 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) MATAM Advanced Technology Park , Building No. 5 , Haifa , Israel 3508409 (Address of principal executive offices) (Zip Code) Registrant's telephone number 011-972-74-7108600 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Shares, par value $0.00001 PLUR The Nasdaq Capital Market Securities registered pursuant to Section 12(g) of the Act: None. (Title of class) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registration was required to submit files). Yes No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one): Large accelerated filer Accelerated filer Non-accelerated filer Smaller reporting company Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No of the issuer's classes of common shares as of the latest practicable date: 6,997,140 common shares issued and outstanding as of February 10, 2025. PART I – FINANCIAL INFORMATION Item 1. Financial Statements PLURI INC. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of December 31, 2024 U.S. DOLLARS IN THOUSANDS (Unaudited) INDEX Page Interim Condensed Consolidated Balance Sheets (Unaudited) 2 Interim Condensed Consolidated Statements of Operations (Unaudited) 4 Interim Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) 5 Interim Condensed Consolidated Statements of Cash Flows (Unaudited) 7 Notes to Interim Condensed Consolidated Financial Statements (Unaudited) 8 1 PLURI INC. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) U.S. Dollars in thousands (except share and per share data) Note December 31, 2024 June 30, 2024 ASSETS CURRENT ASSETS: Cash and cash equivalents $ 7,229 $ 6,783 Short-term bank deposits 14,084 23,202 Restricted cash 261 254 Customer receivables 140 34 Prepaid expenses and other current assets 656 834 Total current assets 22,370 31,107 LONG-TERM ASSETS: Restricted bank deposits 800 634 Severance pay fund 527 470 Property and equipment, net 911 688 Operating lease right-of-use asset 6,236 6,558 Other long-term assets 17 70 Total long-term assets 8,491 8,420 Total assets $ 30,861 $ 39,527 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 2 PLURI INC. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) U.S. Dollars in thousands (except share and per share data) Note December 31, 2024 June 30, 2024 LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT) CURRENT LIABILITIES Trade payables $ 1,165 $ 964 Accrued expenses 841 1,223 Operating lease liability 595 559 Accrued vacation and recuperation 730 702 Other accounts payable 1,109 1,006 Total current liabilities 4,440 4,454 LONG-TERM LIABILITIES Accrued severance pay 637 605 Operating lease liability 4,903 5,026 Loan from the European Investment Bank, or EIB 4 23,798 24,027 Total long-term liabilities 29,338 29,658 COMMITMENTS AND CONTINGENCIES 3 SHAREHOLDERS'

View Full Filing

View this 10-Q filing on SEC EDGAR